Skip to main content

UM School of Medicine's Institute of Human Virology Awarded $40 Million Grant to Conduct HIV Population Surveys

June 24, 2019

Man Charurat, MD

Dr. Man Charurat Completed One of the Largest Population Based HIV/AIDS Survey

Man Charurat, MD, Professor of Medicine, Director, Center for International Health, Education, and Biosecurity (CIHEB), and Director, Division of Epidemiology and Prevention, Institute of Human Virology (IHV) at the University of Maryland School of Medicine (UMSOM), has been awarded a five-year grant from the U.S. Centers for Disease Control and Prevention (CDC) to conduct HIV population-based HIV impact assessments worldwide to measure the progress towards the control of the HIV epidemic. 

The University will receive $40 million in the first year. Dr. Charurat is completing the 20-month Nigeria HIV/AIDS Indicator and Impact Survey (NAIIS), one of the largest population-based HIV/AIDS household surveys ever conducted. The preliminary result of NAIIS was released by the Government of Nigeria and U.S. President’s Emergency Plan for AIDS Relief (PEPFAR) earlier this year.

“This grant allows us to build on our expertise in technical assistance for improving service delivery for HIV/TB prevention, care, treatment, and for associated infectious and non-communicable diseases, and provides more in-depth insights into the HIV epidemics globally,” said Dr. Charurat.

With this new award for a project titled “Regional Strengthening of HIV-focused Population-based National Surveys and Size Estimations (RESPONSE),” the Center will focus survey implementations in several priority countries heavily affected by HIV. The survey combines household visits with key questions and cutting-edge technologies to directly measure national HIV incidence, HIV viral load suppression, and other selected infectious diseases such as HBV, HCV, TB, and syphilis. Under the leadership of each country’s Ministry of Health, survey teams travel door to door to collect risk behavioral data along with biomarkers. Survey results from each country will become available as they are completed over the next five years.

“Dr. Charurat’s important leadership and research in this area will help set the stage to better understand how to intervene and bring an end to HIV prevalence. This is particularly important for the most vulnerable populations. His research team has already conducted significant research and surveillance in Nigeria, which will help form evidence-based HIV intervention policy,” said UMSOM Dean E. Albert Reece, MD, PhD, MBA, who is University Executive Vice President for Medical Affairs, and the John Z. and Akiko K. Bowers Distinguished Professor.

The University leads a consortium comprising of ICF International, the Population Council, the African Field Epidemiology Network, the Association of Public Health Laboratories, and the African Center for Disease Control. In collaboration with the CDC Division of Global HIV and TB, the consortium plays a key role in designing and implementing the PHIA surveys which includes lending expertise in epidemiology, laboratory science, health informatics, survey statistics, and workforce training.

About the Institute of Human Virology

Formed in 1996 as a partnership between the State of Maryland, the City of Baltimore, the University System of Maryland and the University of Maryland Medical System, IHV is an institute of the University of Maryland School of Medicine and is home to some of the most globally-recognized and world-renowned experts in all of virology. The IHV combines the disciplines of basic research, epidemiology and clinical research in a concerted effort to speed the discovery of diagnostics and therapeutics for a wide variety of chronic and deadly viral and immune disorders - most notably, HIV the virus that causes AIDS. For more information, www.ihv.org.

About the Center for International Health, Education and Biosecurity

The Center for International Health, Education, and Biosecurity, founded in 2016, is an international research center created within the University of Maryland School of Medicine by the Institute of Human Virology. CIHEB’s mission is to improve population health, safeguarding communities against health-related threats, and promotes health equity worldwide. CIHEB currently implements 16 programs in six countries with annual funding portfolio of $90M. For more information, www.ciheb.ihv.org and follow us on Twitter @CIHEB_UMB

About the University of Maryland School of Medicine

Now in its third century, the University of Maryland School of Medicine was chartered in 1807 as the first public medical school in the United States. It continues today as one of the fastest growing, top-tier biomedical research enterprises in the world -- with 43 academic departments, centers, institutes, and programs; and a faculty of more than 3,000 physicians, scientists, and allied health professionals, including members of the National Academy of Medicine and the National Academy of Sciences, and a distinguished recipient of the Albert E. Lasker Award in Medical Research.  With an operating budget of more than $1 billion, the School of Medicine works closely in partnership with the University of Maryland Medical Center and Medical System to provide research-intensive, academic and clinically based care for more than 1.2 million patients each year. The School has over 2,500 students, residents, and fellows, and more than $530 million in extramural funding, with most of its academic departments highly ranked among all medical schools in the nation in research funding. As one of the seven professional schools that make up the University of Maryland, Baltimore campus, the School of Medicine has a total workforce of nearly 7,000 individuals. The combined School and Medical System (“University of Maryland Medicine”) has an annual budget of nearly $6 billion and an economic impact more than $15 billion on the state and local community. The School of Medicine faculty, which ranks as the 8th highest among public medical schools in research productivity, is an innovator in translational medicine, with 600 active patents and 24 start-up companies. The School works locally, nationally, and globally, with research and treatment facilities in 36 countries around the world. Visit medschool.umaryland.edu

 

Contact

Institute of Human Virology
Jennifer Gonzales
Public Relations & Communications Manager
jennifer.gonzales@ihv.umaryland.edu

Related stories

    Wednesday, March 20, 2024

    New Study Reveals Insights into Lack of Durability in COVID Antibody Response to Infections & Vaccines

    Researchers at the Institute of Human Virology (IHV) at the University of Maryland School of Medicine published a new study in the Journal of Infectious Diseases investigating the short-lived antibody response following SARS-CoV-2, the virus that causes COVID. 


    Thursday, June 22, 2023

    STAT: A looming penicillin shortage threatens pregnant adults with syphilis and their newborns

    Pfizer announced last week that it expects to run out of a key drug for treating syphilis in the near future — a looming problem that health professionals say could exacerbate syphilis rates, widen racial disparities in sexually transmitted diseases, and stymie global access to the antibiotic, especially within lower-income countries. The drug in question is Bicillin, an injectable, long-acting form of penicillin most commonly used to treat syphilis in adults as well as childhood infections.


    Thursday, April 27, 2023

    Current HIV Research: Milestones: Dr. Robert C. Gallo and the Discovery of HIV-1

    In this issue of the journal, we inaugurate a new series entitled “Milestones.” This series will encompass interviews with some of the pioneers that have laid the foundations of HIV research. Revisiting these landmarks while taking into account the prospect of their founders should be an inspiration to our readers, particularly the youngest generation. Nobody better than Dr. Robert Gallo could be the protagonist of the inaugural “Milestone,” with his recount of the discovery of HIV-1, the causative agent of AIDS, and the development of the first blood test to diagnose HIV-1 infection.


    Wednesday, January 18, 2023

    BBC: The scientist who smuggled HIV in her bag into her country to study it and save lives

    Acquired immune deficiency syndrome, AIDS, had been recognized as a new disease in 1981, when an increasing number of young homosexuals died of unusual infections and rare cancers. It was also known to affect intravenous drug users and some were known to have contracted it through blood transfusions.


    Friday, January 06, 2023

    USA Today: Fact check: Research proves HIV is the cause of AIDS, contrary to viral claim

    The claim: There is no proof HIV is the cause of AIDS. A Dec. 15 Facebook video shows Kary Mullis, a scientist known for denying the link between HIV and AIDS, claiming again there is no proof HIV is the cause of AIDS. The post was shared more than 1,000 times in a week. The clip comes from a 2009 documentary that promoted AIDS denialism, which has more than 300,000 views on YouTube.


    Wednesday, December 21, 2022

    Lead Stories: Fact Check: Doctor Did NOT Say On Video That He Manufactured AIDS As Bio Weapon -- This Is A Soviet-Era Disinformation Hoax

    Did an American doctor admit on video that he created the HIV and AIDS viruses in a U.S. military medical laboratory, Fort Detrick, so that they could be used as biological weapons for depopulating the world? No, that's not true: Dr. Robert Gallo, the doctor featured in the video, makes no such admission in the footage, and told Lead Stories that his scientific work was not part of any plan to weaponize HIV/AIDS. Historical records show that the claim is a well-documented hoax that dates to a Soviet disinformation campaign from the 1980s.


    Thursday, December 01, 2022

    Everyday Health: 10 Facts About HIV/AIDS Everyone Should Know

    A basic understanding of HIV and AIDS can help dispel the myths, erase stigma, prevent virus transmission, and save lives — beginning with your own.


    Monday, October 31, 2022

    NCI Grants Awarded to IHV to Prevent Cancer and Improve Screening in Sub-Saharan Africa

    Institute of Human Virology (IHV) researchers at the University of Maryland School of Medicine (UMSOM) have received two five-year awards from the National Institutes of Health’s National Cancer Institute (NCI) for a total of $7.5 million. One award aims to reduce the incidence of lung cancer and other cancers associated with using tobacco in Botswana. The other is focusing on improving screening and treatment of anal precancer in Nigeria. Both grants will make use of existing HIV treatment and prevention infrastructure in low- and middle-income countries to reach people living with HIV who are most at risk for these particular types of cancers.


    Wednesday, September 28, 2022

    TheBody: What Is HIV Remission?

    A cure for HIV remains elusive, but one word that is commonly heard is “remission.” Even though it doesn’t mean eradication of the virus, remission is a good thing. But what exactly is remission? Can HIV go into remission? And how does it differ from a cure? Generally, remission means that a disease has stopped being active but hasn’t necessarily been eliminated.


    Monday, September 19, 2022

    TheBody: HIV Seroconversion: Timeline, Symptoms, Testing, and Treatment

    There are several stages of HIV infection—from the initial exposure to the virus to the development of AIDS—but a lot of important changes happen during the earliest stage: seroconversion. So, exactly what is HIV seroconversion? It is the stage in which the immune system first starts to make antibodies to try to fight HIV after exposure. Once detectable levels of antibodies are produced, this is described as seroconversion.


    Monday, September 19, 2022

    TheBody: What Are the Chances of Getting HIV from One Exposure?

    You had a one-night stand with someone of questionable HIV status. Now the panic begins. Could you have HIV after only one exposure? What are the odds?


    Tuesday, July 19, 2022

    Six-Country African Study Shows COVID-19 Can Be Dangerous in Pregnancy

    A new study involving hospitalized women in six African countries from the University of Maryland School of Medicine’s (UMSOM) Institute of Human Virology (IHV) showed that pregnant women with SARS-CoV-2, the virus that causes COVID-19, had double the risk of being admitted to the intensive care unit (ICU) and four-times the risk of dying in-hospital than pregnant women who did not have COVID-19.


    Thursday, June 23, 2022

    New Research Shows Mothers’ HIV Status, Breastfeeding, and the Infant Gut Microbiome Can Have Long-Term Impact on Infant Health

    Babies born to women with HIV often have poorer health and under-developed growth in the early months of life than infants born to women without the infection — even if those babies don’t contract HIV during birth, according to a new study by researchers at the University of Maryland School of Medicine (UMSOM)’s Institute for Genome Sciences (IGS) and Institute of Human Virology (IHV). The study also provides new insights into why these health issues often continue throughout the babies’ lives.


    Tuesday, May 31, 2022

    Medscape: Fatigue Affects Cognitive Processing Speed in the Aging HIV Population

    Successful aging is something that most of us strive for. But with aging comes a pervasive condition called fatigue that, in many older adults, interferes with everyday functioning, mental health, social support, and overall quality of life. The relationship between fatigue and cognitive and functional impairment is one of particular interest in people living with HIV (PWH), a patient population that is disproportionately affected but whose lifespan now matches that of the general population.


    Wednesday, May 25, 2022

    NIH Awards Grant to Train Global Health Scientists in Low-and-Middle-Income Countries

    Researchers at the University of Maryland School of Medicine (UMSOM) received a $5.5 million award from the National Institute of Health’s Fogarty International Center to help foster the next generation of global health scientists. The award entitled, “Integrated Network of Scholars in Global Health Research Training (INSIGHT)” will expand global health research across sub-Saharan Africa, South Asia, Latin America, and the Caribbean by providing one-year mentored research training to U.S. and lower-middle income country scholars.


    Friday, May 20, 2022

    NIH Grant Awarded to Study HIV Drug-Resistant Genetic Mutations Across Africa

    University of Maryland School of Medicine (UMSOM)’s Institute of Human Virology (IHV) researchers received funding from the National Institutes of Health’s National Institute of Allergy and Infectious Diseases (NIAID) for $2.7 million to study genetic changes in two genes from the HIV-1 virus that may make it resistant to antiretroviral therapy. The study, named INSPIRE, will analyze genetic variation in types of HIV circulating in a handful of African countries that will help to better understand the implications of these mutations and will improve clinical management of patients.


    Tuesday, May 10, 2022

    Medscape: Decentralizing PrEP Offers a Roadmap for Retention

    Good solutions have great roadmaps. For HIV preexposure prophylaxis (PrEP), the road map might just be that of contraceptive care. Once an onerous process, over time contraceptive care exploded into a range of options across a broad landscape in terms of approach and accessibility. How then do organizations help vulnerable patients navigate their PrEP journeys using the contraceptive roadmap as a guide?


    Friday, March 18, 2022

    Deutsche Presse-Agentur: Virus hunt for decades: US researcher Robert Gallo turns 85

    Few scientists in the world can come up with as many successes as Robert Gallo: The US researcher was involved in the discovery of the AIDS virus, found leukemia pathogens and other deadly viruses. Now he is 85 - and works even harder than before.


    Thursday, March 10, 2022

    Healthline: HIV-1 May Be More Virulent When Transmitted Through Penile-Vaginal Intercourse

    HIV-1 can be transmitted through vaginal, anal, and oral sex, whether it’s with a same-sex or different-sex partner. But the risk of developing it seems to vary depending on how the disease is transmitted. In fact, the HIV virus may be more virulent when passed between male and female partners who have penile-vaginal sex than among men who have anal sex with other men, according to a new study from the Indian Institute of Science.


    Thursday, March 10, 2022

    HIV Plus: One Woman Shares Her Journey of Living with HIV for Over Three Decades

    In honoring long-term survivors and National Women and Girls HIV Awareness Day on March 10, I had the opportunity to speak with Ms. Kathy Bennett. She is a 63-year-old Black woman who has been living with HIV for over 31 years. She recently led the longest running HIV support group in Maryland.


    Wednesday, February 16, 2022

    WBAL: Maryland HIV researcher on latest research: It's not a cure

    Scientists used a cutting-edge stem cell transplant method to treat a woman's HIV, but a lead researcher in Maryland said it's too soon to celebrate. A U.S. woman is the third known person who is in HIV remission after receiving stem cells from umbilical cord blood, an American research team announced Wednesday.


    Monday, February 07, 2022

    The GW Hatchet: University administers first doses of mRNA HIV vaccine through Moderna partnership

    GW was one of the first institutions in the country to administer doses of the first mRNA HIV vaccines to human test subjects late last month. The School of Medicine and Health Sciences and its Vaccine Research Unit collaborated with Moderna to test the safety of the vaccine and the immune responses of two participants in the phase 1 clinical trial.


    Friday, February 04, 2022

    WYPR: How the COVID pandemic rattled HIV testing

    The COVID pandemic did not end the HIV-AIDS epidemic; it may have obscured it for a while, raising hurdles to getting tested for HIV.


    Wednesday, January 26, 2022

    STAT: Early research suggests cancer drug could help flush HIV from its hiding spots

    In a study published Wednesday in Science Translational Medicine, researchers looked at 32 patients that had both cancer and HIV and found that pembrolizumab, which revives the immune system and encourages it to attack tumors, also has the ability to flush HIV out of its hiding spot in immune cells.


    Wednesday, November 10, 2021

    Omaha World-Herald: UNMC researchers develop 'molecular scissors' to target HIV

    Researchers at the University of Nebraska Medical Center have used a new method they’re calling a “molecular scissors” to nearly eliminate HIV embedded in the genetic material of human cells.


    Thursday, November 04, 2021

    University of Maryland School of Medicine Institute of Human Virology Researchers Receive $6.5M to Create African Big Data Hub Designed to Address Public Health and Pandemic Preparedness

    Researchers at the University of Maryland School of Medicine (UMSOM)’s Institute of Human Virology (IHV), a Global Virus Network (GVN) Center of Excellence, have received $6.5 million from the U.S. National Institutes of Health (NIH) to streamline big data collection in Nigeria and South Africa in addressing public health needs of the COVID-19 and HIV pandemics.


    Tuesday, July 06, 2021

    UM School of Medicine Researchers Receive NIH Avant-Garde Award for Out-Of-Box Concept to Cure HIV and Treat Co-Existing Addiction

    Linda Chang, MD, MS, Professor of Diagnostic Radiology & Nuclear Medicine at the University of Maryland School of Medicine (UMSOM), received the National Institute on Drug Abuse (NIDA) 2021 Avant-Garde Award (DP1) for HIV/AIDS and Substance Use Disorder Research, a National Institutes of Health (NIH) Director’s Pioneer Award. This prestigious award supports researchers with exceptional creativity, who propose high-impact research with the potential to be transformative to the field. She will work with Institute for Human Virology (IHV) researchers for this project.


    Monday, June 07, 2021

    POZ: Integrate Adult and Pediatric HIV Care to Ease Youth Transition to Adult Care

    Embedding an adult HIV medicine clinician and care navigator into a Baltimore pediatric HIV clinic led to 95% of young people remaining engaged in adult care one year after transition, according to a report in AIDS Care.


    Thursday, May 27, 2021

    Baltimore Sun: Maryland researchers study whether HIV cure can come from infusing patients with genetically modified ‘super T cells’

    A week ago, a Washington, D.C., man in his 30s with HIV became the first person to be infused with a heaping load of his own genetically modified cells that a Maryland biotech firm believes one day could lead to the elusive cure for the disease. American Gene Technologies’ method involves taking T cells out of a person’s blood and genetically modifying them in the lab to resist infection before they are reinfused. C. David Pauza is the company’s chief science officer and a former professor and researcher at the University of Maryland School of Medicine’s Institute for Human Virology. Another center evaluating entering the study is Maryland’s Institute for Human Virology, confirmed its co-founder and director, Dr. Robert Gallo, who is internationally regarded for his role in discovering HIV and developing a blood test to detect it.


    Thursday, April 01, 2021

    A Statement from the Leadership of the University of Maryland School of Medicine’s Institute of Human Virology on the Passing of Dr. John Martin

    The Institute of Human Virology at the University of Maryland School of Medicine mourns the passing of IHV 2014 Lifetime Achievement Public Service Awardee and 2017 Annual Marlene and Stewart Greenebaum Lecturer, John Martin, PhD. Dr. Martin was a leader in supporting access to life-saving anti-HIV medications that although still under patent were made widely and affordably available to millions around the world infected with HIV, and for prevention through pre-exposure drug therapy. He was a tremendous clinical scientist, businessman, global public health leader, philanthropist, and good friend.


    Monday, August 03, 2020

    Infectious Disease Special Edition: COVID-19 and HIV: Was It a Deadly Mix?

    Social distancing is one of the curses of COVID-19, and may fall more heavily on people with HIV than on those without this burden. “People with HIV, and in particular certain subsets of that group—the LGBTQ community, older adults aging with HIV, etc.—face more mental health issues than the general population,” said Sarah Schmalzle, MD, an assistant professor of medicine at the Institute of Human Virology, University of Maryland School of Medicine, in Baltimore. “Many of our patients also already face significant isolation and loneliness due to a combination of HIV stigma, losses of friends and family to HIV, and aging.”


    Tuesday, July 07, 2020

    Courthouse News Service: Global Progress on Ending HIV/AIDS Derailed by Covid-19

    A United Nations program aimed at eliminating HIV/AIDS released a report Monday showing that the global response to the epidemic has fallen far short of goals set for 2020, in large part due to the coronavirus pandemic.


    Saturday, April 11, 2020

    Institute of Human Virology Honors Legacy of Maeve Kennedy McKean With Global Public Health Fellowship

    The Institute of Human Virology (IHV) at the University of Maryland School of Medicine announced today the Maeve Kennedy McKean Global Public Health Fellowship, named in honor of the public health activist, whose inspiring life ended tragically alongside her oldest son last week. The first fellow will arrive on July 1 and will work on the Institute’s efforts in ending the HIV epidemic in Africa within its Center for International Health, Education, and Biosecurity (CIHEB) and Division of Clinical Care and Research.


    Thursday, October 17, 2019

    A Statement from the Leadership of the Institute of Human Virology on the Passing of The Honorable Elijah Cummings

    The Institute of Human Virology (IHV) at the University of Maryland School of Medicine mourns the passing of The Honorable Elijah Cummings, a lifelong Baltimorean, a member of the U.S. House of Representatives representing Maryland’s 7th District, and, among other prominent positions, a member of IHV’s Board of Advisors.


    Wednesday, May 01, 2019

    Large National Survey Shows Smaller HIV Epidemic in Nigeria Than Once Thought and Highlights Key Gaps

    (CDC) The Government of Nigeria, the U.S. President’s Emergency Plan for AIDS Relief (PEPFAR), CDC, and the University of Maryland School of Medicine released new data from the Nigeria HIV/AIDS Indicator and Impact Survey (NAIIS), one of the largest population-based HIV/AIDS household surveys ever conducted. The NAIIS directly measured HIV prevalence and viral load suppression. According to the NAIIS results, the HIV prevalence in Nigeria is lower than previously thought, allowing the country to focus on providing services to the areas of greatest need to control the HIV epidemic.


    Wednesday, March 06, 2019

    UMSOM Researcher Elected as Fellow to American Academy of Microbiology

    Richard Y. Zhao, Ph.D., Professor of Pathology and Associate Member of the Institute of Human Virology (IHV) at the University of Maryland School of Medicine (UMSOM), has been elected as a Fellow to the American Academy of Microbiology (AAM). AAM is an honorific leadership group within the American Society for Microbiology (ASM).


    Tuesday, December 11, 2018

    Institute of Human Virology's Shyam Kottilil to Receive National Award from American College of Physicians

    The American College of Physicians announced that Shyam Kottilil, MBBS, PhD, FACP, Professor of Medicine and Director of the Division of Clinical Care and Research at the Institute of Human Virology (IHV) of the University of Maryland School of Medicine (UMSOM) and Chief of the Division of Infectious Diseases, was awarded the American College of Physicians (ACP) Richard and Hinda Rosenthal Award #1 from the Rosenthal Family Foundation.


    Tuesday, December 04, 2018

    Institute of Human Virology Researchers Discover That a Bacterial Protein Promotes Cancer

    The Institute of Human Virology (IHV) at the University of Maryland School of Medicine (UMSOM) announced today the discovery that DnaK, a protein of the bacterium mycoplasma, interferes with the mycoplasma-infected cell’s ability to respond to and repair DNA damage, a known origin of cancer.


    Monday, December 03, 2018

    Institute of Human Virology Names Dr. Man Charurat as Director of the Center for International Health, Education, and Biosecurity

    The Institute of Human Virology (IHV) at the University of Maryland School of Medicine today announced the appointment of Man E. Charurat, PhD, MHS, Professor of Medicine and Director of the Division of Epidemiology and Prevention at the IHV as the Director of IHV’s Center for International Health, Education, and Biosecurity (CIHEB). Dr. Charurat will replace Deus Bazira, DrPH, MPH, MBA. The announcement was made by Robert C. Gallo, MD, The Homer & Martha Gudelsky Distinguished Professor in Medicine, Co-Founder and Director of the IHV, and Co-Founder and Director of the Global Virus Network (GVN).


    Tuesday, October 23, 2018

    Institute of Human Virology Hosts 20th Annual International Meeting of Top Medical Virus Researchers in Baltimore, Maryland

    The Institute of Human Virology (IHV) at the University of Maryland School of Medicine yesterday commenced IHV’s 20th Annual International Meeting, to be held through Thursday, October, 25 at the Four Seasons Hotel in Baltimore, Maryland. This year, among other viral and cancer related topics, the meeting is holding special sessions on the 40th anniversary of the first human retrovirus, Human T cell Leukemia Virus (HTLV), and the 15th anniversary of the President’s Emergency Plan for AIDS Relief (PEPFAR). IHV’s Annual International Meeting attracts hundreds of elite scientists who descend upon Baltimore to share ideas and inspire medical virus research collaborations.


    Wednesday, August 02, 2017

    UM School of Medicine Receives $2 Million Grant for HIV Research in Malawi

    The University of Maryland School of Medicine’s (UM SOM) Institute for Global Health (IGH) and the Institute of Human Virology (IHV) have been awarded a $2 million five-year grant from the Eunice Kennedy Shriver National Institute of Child Health and Human Development to study the impact exposure to HIV has on the immune systems of infants in utero and how those changes impact the ability of infants to fight off infections after birth.


    Tuesday, November 22, 2016

    IHV Awarded $138M to combat HIV/AIDS in Africa & Launches Center for International Health, Education, & Biosecurity

    The Institute of Human Virology (IHV) at the University of Maryland School of Medicine announced today more than $138 million in multiple five-year grants awarded by the Centers for Disease Control and Prevention to combat HIV/AIDS in Kenya, Tanzania, Zambia, and Nigeria. The Institute concurrently announced the formation of the IHV Center for International Health, Education, & Biosecurity (CIHEB), and its newly appointed director, Deus Bazira Mubangizi, DrPH, MBA, MPH, Assistant Professor of Medicine, Director, Center for Health, Education, & Biosecurity, Institute of Human Virology, University of Maryland School of Medicine.


    Tuesday, October 25, 2016

    "A Call to End HIV/AIDS in America" IHV Director Dr. Robert Gallo's Op-Ed in the Huffington Post

    As the new Administration is presented with great challenges facing the United States, one will be a longtime foe, the U.S. HIV/AIDS epidemic. Since President Barack Obama was elected in 2008, I have publicly called on our country’s leaders to utilize the largest global health initiative in history - the President’s Emergency Plan for AIDS Relief (PEPFAR) - as a model to address the U.S. epidemic.